Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ORMPORAMED PHARMACEUTICALS INC.

Nasdaq · CIK 0001176309
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts621

Identity from submissions API

NameORAMED PHARMACEUTICALS INC.
CIK0001176309
TickersORMP
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN980376008
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone646-844-1164
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)1

Former names

  • Integrated Security Technologies, Inc. (2004-06-14T00:00:00.000Z → 2006-04-10T00:00:00.000Z)
  • IGUANA VENTURES LTD (2002-11-29T00:00:00.000Z → 2004-06-10T00:00:00.000Z)
Business address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR
NEW YORK
NY
10036
NY
Mailing address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR
NEW YORK
NY
10036
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

952 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 8-K CURRENT REPORT 8.01 0001213900-26-122239 001-35813 261574809 34 187456 1 1
2026-11-13 4 xslF345X06/ownership.xml 0001213900-26-120039 7523
2026-11-13 4 xslF345X06/ownership.xml 0001213900-26-120038 8381
2026-11-13 4 xslF345X06/ownership.xml 0001213900-26-120037 7533
2026-11-13 4 xslF345X06/ownership.xml 0001213900-26-120036 7509
2026-11-13 4 xslF345X06/ownership.xml 0001213900-26-120035 7557
2026-11-13 4 xslF345X06/ownership.xml 0001213900-26-120034 7561
2026-11-13 4 xslF345X06/ownership.xml 0001213900-26-120033 7586
2026-11-13 4 xslF345X06/ownership.xml 0001213900-26-120032 7566
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-051853 005-79895 261554130 34 7282
2026-11-12 10-Q QUARTERLY REPORT 0001213900-26-119064 001-35813 261548182 34 8983249 1 1
2026-10-02 4 xslF345X06/ownership.xml 0001213900-26-106531 5595
2026-10-02 4 xslF345X06/ownership.xml 0001213900-26-106530 5571
2026-10-01 144 xsl144X01/primary_doc.xml 0001976408-26-000877 001-35813 261428951 33 5431
2026-10-01 144 xsl144X01/primary_doc.xml 0001976408-26-000876 001-35813 261428947 33 6046
2026-09-25 4 xslF345X06/ownership.xml 0001213900-26-103540 22650
2026-09-25 4 xslF345X06/ownership.xml 0001213900-26-103538 14811
2026-09-25 4 xslF345X06/ownership.xml 0001213900-26-103536 21759
2026-09-25 4 xslF345X06/ownership.xml 0001213900-26-103535 5662
2026-09-17 8-K CURRENT REPORT 5.07 0001213900-26-100929 001-35813 261386659 34 204872 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-038125 005-79895 261278253 34 7224
2026-08-10 10-Q QUARTERLY REPORT 0001213900-26-087361 001-35813 261259737 34 9009005 1 1
2026-08-03 ARS ARS 0001213900-26-084613 001-35813 261232848 34 575395
2026-08-03 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-26-084612 001-35813 261232835 34 4814585
2026-08-03 DEF 14A PROXY STATEMENT 0001213900-26-084609 001-35813 261232822 34 8876200 1 1
2026-07-22 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001213900-26-080406 10069
2026-07-02 4 OWNERSHIP DOCUMENT 0001213900-26-075070 9448
2026-07-02 4 OWNERSHIP DOCUMENT 0001213900-26-075069 5628
2026-07-01 144 xsl144X01/primary_doc.xml 0001976408-26-000609 001-35813 261143680 33 5383
2026-07-01 144 xsl144X01/primary_doc.xml 0001976408-26-000608 001-35813 261143552 33 4768
2026-06-30 8-K CURRENT REPORT 5.03,8.01,9.01 0001213900-26-073709 001-35813 261140756 34 347809 1 1
2026-06-29 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001373604-26-000047 005-79895 261132417 34 8443
2026-06-17 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001213900-26-069783 18356
2026-05-19 10-Q QUARTERLY REPORT 0001213900-26-059112 001-35813 261000187 34 7113366 1 1
2026-05-15 NT 10-Q NOTIFICATION OF LATE FILING 0001213900-26-057722 001-35813 26987034 34 21603
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-023496 005-79895 26984619 34 7062
2026-05-14 3 xslF345X06/ownership.xml 0001213900-26-056839 001-36612 26980499 34 10712
2026-05-14 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001213900-26-056837 21317
2026-03-31 8-K CURRENT REPORT 1.01,2.01 0001213900-26-037474 001-35813 26822218 34 193975 1 1
2026-03-31 4 xslF345X06/ownership.xml 0001213900-26-037447 6050
2026-03-31 4 xslF345X06/ownership.xml 0001213900-26-037446 5355
2026-03-26 10-K ANNUAL REPORT 0001213900-26-034835 001-35813 26799395 34 12255141 1 1
2026-03-18 4 xslF345X06/ownership.xml 0001213900-26-031015 5163
2026-03-18 4 xslF345X06/ownership.xml 0001213900-26-031013 5154
2026-03-18 4 xslF345X06/ownership.xml 0001213900-26-031012 5157
2026-03-18 4 xslF345X06/ownership.xml 0001213900-26-031011 5181
2026-03-16 4 xslF345X05/ownership.xml 0001213900-26-028291 5042
2026-02-20 8-K 8-K 1.01,9.01 0001012975-26-000195 001-35813 26660328 34 756649 1 1
2026-02-19 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-26-018576 19658
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001012975-26-000138 8486
2026-02-09 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001373604-26-000012 005-79895 26610905 34 8306
2026-01-29 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-26-009570 39012
2026-01-29 4 xslF345X05/ownership.xml 0001213900-26-009477 7554
2026-01-29 4 xslF345X05/ownership.xml 0001213900-26-009478 7559
2026-01-29 4 xslF345X05/ownership.xml 0001213900-26-009476 7578
2026-01-29 4 xslF345X05/ownership.xml 0001213900-26-009479 7553
2026-01-21 4 xslF345X05/ownership.xml 0001213900-26-006215 5050
2026-01-14 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-26-004382 001-35813 26533626 34 1979606 1 1
2026-01-07 8-K CURRENT REPORT 8.01,9.01 0001213900-26-001983 001-35813 26514200 34 198158 1 1
2026-01-05 4 xslF345X05/ownership.xml 0001213900-26-001282 6850
2026-01-05 4 xslF345X05/ownership.xml 0001213900-26-001280 10079
2026-01-05 4 xslF345X05/ownership.xml 0001213900-26-001279 9381
2026-01-05 4 xslF345X05/ownership.xml 0001213900-26-001278 9374
2026-01-05 4 xslF345X05/ownership.xml 0001213900-26-001277 7708
2026-01-05 4 xslF345X05/ownership.xml 0001213900-26-001275 6785
2026-01-02 4 xslF345X05/ownership.xml 0001213900-26-000661 6836
2026-01-02 4 xslF345X05/ownership.xml 0001213900-26-000658 9397
2025-12-31 8-K CURRENT REPORT 5.02 0001213900-25-127133 001-35813 251617726 34 188948 1 1
2025-12-31 8-K 8-K 8.01 0001012975-25-000992 001-35813 251615565 34 159852 1 1
2025-11-17 8-K CURRENT REPORT 2.02,9.01 0001213900-25-111310 001-35813 251489522 34 199426 1 1
2025-11-17 8-A12B FOR REGISTRATION OF CERTAIN CLASSES 0001213900-25-111299 001-35813 251489483 34 280998
2025-11-17 8-K CURRENT REPORT 1.01,3.03,9.01 0001213900-25-111298 001-35813 251489482 34 514909 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001012975-25-000769 8356
2025-11-13 10-Q QUARTERLY REPORT 0001213900-25-109980 001-35813 251478439 34 6748868 1 1
2025-10-24 8-K CURRENT REPORT 1.01,1.02,2.02,8.01,9.01 0001213900-25-101825 001-35813 251414042 34 274827 1 1
2025-10-06 8-K CURRENT REPORT 8.01 0001213900-25-096322 001-35813 251375895 34 187482 1 1
2025-08-28 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-081720 005-79895 251273211 34 10375
2025-08-21 S-8 REGISTRATION STATEMENT 0001213900-25-079364 333-289761 251240883 33 200136 1 1
2025-08-21 8-K CURRENT REPORT 5.02,5.07 0001213900-25-079361 001-35813 251240790 34 213383 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-076929 8118
2025-08-14 10-Q QUARTERLY REPORT 0001213900-25-076668 001-35813 251219133 34 6678333 1 1
2025-07-23 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-25-066819 001-35813 251141694 34 346516 1 1
2025-07-16 ARS FORM ARS 0001213900-25-064758 001-35813 251128050 34 613286
2025-07-16 DEF 14A PROXY STATEMENT 0001213900-25-064755 001-35813 251128038 34 4119838 1 1
2025-07-16 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001213900-25-064678 001-35813 251127430 34 429056 1 1
2025-06-09 4 xslF345X05/ownership.xml 0001213900-25-052624 6672
2025-06-09 4 xslF345X05/ownership.xml 0001213900-25-052623 6723
2025-06-09 4 xslF345X05/ownership.xml 0001213900-25-052622 6736
2025-06-09 4 xslF345X05/ownership.xml 0001213900-25-052620 6679
2025-06-09 4 xslF345X05/ownership.xml 0001213900-25-052618 7593
2025-05-21 8-K CURRENT REPORT 8.01 0001213900-25-046436 001-35813 25973126 34 186885 1 1
2025-05-15 10-Q QUARTERLY REPORT 0001213900-25-044193 001-35813 25952806 34 5730496 1 1
2025-05-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-041073 8910
2025-05-01 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-038294 86471
2025-04-28 8-K CURRENT REPORT 1.01,7.01,9.01 0001213900-25-036109 001-35813 25880853 34 425384 1 1
2025-03-27 10-K ANNUAL REPORT 0001013762-25-003450 001-35813 25780273 34 9840758 1 1
2025-03-03 8-K CURRENT REPORT 1.01,9.01 0001213900-25-019437 001-35813 25698463 34 1206748 1 1
2025-02-27 8-K CURRENT REPORT 1.01,9.01 0001213900-25-018135 001-35813 25680431 34 664693 1 1
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001373604-25-000022 005-79895 25621024 34 6702
2025-02-11 8-K CURRENT REPORT 1.01,7.01,9.01 0001213900-25-012244 001-35813 25610350 34 1699009 1 1
2025-02-11 4 xslF345X05/ownership.xml 0001213900-25-012241 8505
2025-02-11 4 xslF345X05/ownership.xml 0001213900-25-012240 8497
2025-02-11 4 xslF345X05/ownership.xml 0001213900-25-012239 9204
2025-02-11 4 xslF345X05/ownership.xml 0001213900-25-012238 6780
2025-01-22 8-K CURRENT REPORT 1.01,9.01 0001213900-25-005212 001-35813 25544025 34 253606 1 1
2025-01-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-004622 8878
2025-01-06 4 xslF345X05/ownership.xml 0001213900-25-001168 5704
2025-01-06 4 xslF345X05/ownership.xml 0001213900-25-001166 5027
2025-01-06 4 xslF345X05/ownership.xml 0001213900-25-001169 5008
2025-01-06 4 xslF345X05/ownership.xml 0001213900-25-001165 5002
2025-01-03 8-K CURRENT REPORT 1.01,9.01 0001213900-25-000517 001-35813 25503821 34 284322 1 1
2024-12-17 8-K CURRENT REPORT 8.01 0001213900-24-109825 001-35813 241556427 34 200299 1 1
2024-11-08 4 xslF345X05/ownership.xml 0001213900-24-095932 4966
2024-11-08 4 xslF345X05/ownership.xml 0001213900-24-095931 5625
2024-11-08 4 xslF345X05/ownership.xml 0001213900-24-095930 4928
2024-11-08 4 xslF345X05/ownership.xml 0001213900-24-095929 4923
2024-11-07 10-Q QUARTERLY REPORT 0001213900-24-095397 001-35813 241435541 34 4056135 1 1
2024-10-29 8-K CURRENT REPORT 8.01 0001213900-24-091795 001-35813 241406528 34 207776 1 1
2024-10-08 8-K CURRENT REPORT 1.01,7.01,8.01,9.01 0001213900-24-086214 001-35813 241359954 34 2979856 1 1
2024-09-26 8-K CURRENT REPORT 1.01,9.01 0001213900-24-082237 001-35813 241328843 34 289416 1 1
2024-09-23 8-K CURRENT REPORT 8.01,9.01 0001213900-24-080812 001-35813 241314665 34 235514 1 1
2024-09-16 SC 13G ormp13g.htm 0001373604-24-000092 005-79895 241301626 34 55864
2024-08-14 10-Q QUARTERLY REPORT 0001213900-24-068992 001-35813 241207507 34 3503910 1 1
2024-08-02 8-K CURRENT REPORT 5.07 0001213900-24-064732 001-35813 241170932 34 211065 1 1
2024-06-26 8-K CURRENT REPORT 8.01 0001213900-24-055950 001-35813 241070822 34 194494 1 1
2024-06-24 8-K CURRENT REPORT 8.01 0001213900-24-055006 001-35813 241062219 34 200242 1 1
2024-06-21 4 xslF345X05/ownership.xml 0001213900-24-054781 5096
2024-06-21 3 xslF345X02/ownership.xml 0001213900-24-054773 3156
2024-06-20 ARS FORM ARS 0001213900-24-054008 001-35813 241054075 34 1458029
2024-06-20 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-24-054007 001-35813 241054068 34 2250602
2024-06-10 8-K CURRENT REPORT 5.02 0001213900-24-051355 001-35813 241033882 34 206551 1 1
2024-06-10 4 xslF345X05/ownership.xml 0001213900-24-051336 5014
2024-05-13 8-K CURRENT REPORT 5.02 0001213900-24-041847 001-35813 24936323 34 197174 1 1
2024-05-09 10-Q QUARTERLY REPORT 0001213900-24-041364 001-35813 24931705 34 3266077 1 1
2024-05-06 8-K CURRENT REPORT 8.01 0001213900-24-039909 001-35813 24916042 34 201311 1 1
2024-04-18 4 xslF345X05/ownership.xml 0001213900-24-034222 5191
2024-04-02 3 xslF345X02/ownership.xml 0001213900-24-029454 3150
2024-03-22 SC 13D SCHEDULE 13D 0001213900-24-025263 005-79895 24776738 34 44454
2024-03-19 8-K CURRENT REPORT 8.01 0001213900-24-023721 001-35813 24761136 34 198785 1 1
2024-03-18 8-K CURRENT REPORT 5.02 0001213900-24-023584 001-35813 24760046 34 198806 1 1
2024-03-18 8-K CURRENT REPORT 1.01,1.02,9.01 0001213900-24-023571 001-35813 24759932 34 648170 1 1
2024-03-18 424B5 PROSPECTUS SUPPLEMENT 0001213900-24-023564 333-257926 24759877 33 271208
2024-03-06 10-K ANNUAL REPORT 0001213900-24-020485 001-35813 24726812 34 8257559 1 1
2024-02-20 8-K CURRENT REPORT 8.01,9.01 0001213900-24-015108 001-35813 24650992 34 231879 1 1
2024-01-30 4 FORM 4 SUBMISSION 0001209191-24-002429 5051
2024-01-23 8-K CURRENT REPORT 1.01,9.01 0001213900-24-005780 001-35813 24553172 34 834434 1 1
2024-01-19 8-K CURRENT REPORT 5.02 0001213900-24-004905 001-35813 24546179 34 194319 1 1
2024-01-08 4 FORM 4 SUBMISSION 0001209191-24-001154 5054
2024-01-08 4 FORM 4 SUBMISSION 0001209191-24-001151 5766
2024-01-08 4 FORM 4 SUBMISSION 0001209191-24-001148 5063
2024-01-08 4 FORM 4 SUBMISSION 0001209191-24-001146 5071
2024-01-08 4 FORM 4 SUBMISSION 0001209191-24-001143 6825
2024-01-08 4 FORM 4 SUBMISSION 0001209191-24-001141 6815
2024-01-08 4 FORM 4 SUBMISSION 0001209191-24-001137 6819
2024-01-08 4 FORM 4 SUBMISSION 0001209191-24-001135 6869
2024-01-08 4 FORM 4 SUBMISSION 0001209191-24-001131 7741
2024-01-02 3 FORM 3 SUBMISSION 0001209191-24-000041 3172
2023-12-21 8-K CURRENT REPORT 8.01 0001213900-23-097505 001-35813 231503040 34 199738 1 1
2023-12-18 8-K CURRENT REPORT 5.02 0001213900-23-096536 001-35813 231494389 34 199920 1 1
2023-11-09 10-Q QUARTERLY REPORT 0001213900-23-085310 001-35813 231393707 34 3567600 1 1
2023-09-26 8-K CURRENT REPORT 1.01,1.02,7.01,9.01 0001213900-23-079586 001-35813 231280853 34 2377176 1 1
2023-09-13 8-K CURRENT REPORT 8.01,9.01 0001213900-23-076238 001-35813 231251680 34 474471 1 1
2023-08-22 8-K CURRENT REPORT DATED AUGUST 17, 2023 1.01,8.01,9.01 0001213900-23-069538 001-35813 231190470 34 244367 1 1
2023-08-10 10-Q QUARTERLY REPORT 0001213900-23-065678 001-35813 231160472 34 3159374 1 1
2023-08-09 8-K CURRENT REPORT 1.01,9.01 0001213900-23-064786 001-35813 231153495 34 1117555 1 1
2023-08-07 8-K CURRENT REPORT 8.01,9.01 0001213900-23-063876 001-35813 231145881 34 308945 1 1
2023-07-13 8-K CURRENT REPORT 5.07 0001213900-23-056806 001-35813 231087299 34 219323 1 1
2023-05-31 ARS FORM ARS 0001213900-23-044532 001-35813 23982102 34 1394597
2023-05-31 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-23-044530 001-35813 23982088 34 1914496
2023-05-31 4 FORM 4 SUBMISSION 0001209191-23-033145 5640
2023-05-31 4 FORM 4 SUBMISSION 0001209191-23-033143 4935
2023-05-31 4 FORM 4 SUBMISSION 0001209191-23-033144 4967
2023-05-31 4 FORM 4 SUBMISSION 0001209191-23-033142 4921
2023-05-31 4 FORM 4 SUBMISSION 0001209191-23-033141 4952
2023-05-11 10-Q QUARTERLY REPORT 0001213900-23-038593 001-35813 23912027 34 2735802 1 1
2023-05-01 4 FORM 4 SUBMISSION 0001209191-23-026306 5822
2023-05-01 3 FORM 3 SUBMISSION 0001209191-23-026305 3983
2023-05-01 8-K CURRENT REPORT 5.02 0001213900-23-034728 001-35813 23874604 34 198895 1 1
2023-04-20 4 FORM 4 SUBMISSION 0001209191-23-024942 4898
2023-04-20 4 FORM 4 SUBMISSION 0001209191-23-024941 4998
2023-04-20 4 FORM 4 SUBMISSION 0001209191-23-024940 4953
2023-04-20 4 FORM 4 SUBMISSION 0001209191-23-024939 5672
2023-04-20 4 FORM 4 SUBMISSION 0001209191-23-024938 4901
2023-04-20 4 FORM 4 SUBMISSION 0001209191-23-024937 4968
2023-04-20 4 FORM 4 SUBMISSION 0001209191-23-024936 4983
2023-04-20 4 FORM 4 SUBMISSION 0001209191-23-024935 4891
2023-04-04 4 FORM 4 SUBMISSION 0001209191-23-022815 6645
2023-03-16 4 FORM 4 SUBMISSION 0001209191-23-019367 5871
2023-03-15 4 FORM 4 SUBMISSION 0001209191-23-018956 5367
2023-03-15 4 FORM 4 SUBMISSION 0001209191-23-018952 4972
2023-03-15 4 FORM 4 SUBMISSION 0001209191-23-018944 7125
2023-03-06 10-K ANNUAL REPORT 0001213900-23-017837 001-35813 23709740 34 9022584 1 1
2023-02-27 8-K CURRENT REPORT 5.03,9.01 0001213900-23-014884 001-35813 23676393 34 536293 1 1
2023-01-12 8-K CURRENT REPORT 8.01 0001213900-23-002343 001-35813 23524662 34 202939 1 1
2023-01-04 4 FORM 4 SUBMISSION 0001209191-23-000517 7012
2022-12-12 8-K CURRENT REPORT 7.01,9.01 0001213900-22-078902 001-35813 221456154 34 12286617 1 1
2022-11-14 8-K CURRENT REPORT 8.01 0001213900-22-071607 001-35813 221380386 34 196597 1 1
2022-11-10 8-K CURRENT REPORT 2.02,9.01 0001213900-22-071230 001-35813 221377840 34 295579 1 1
2022-11-10 10-Q QUARTERLY REPORT 0001213900-22-071222 001-35813 221377790 34 3439054 1 1
2022-10-28 4 FORM 4 SUBMISSION 0001209191-22-054879 4938
2022-09-19 8-K CURRENT REPORT 5.03,9.01 0001213900-22-057036 001-35813 221251222 34 488183 1 1
2022-09-13 8-K CURRENT REPORT 8.01 0001213900-22-055429 001-35813 221239800 34 202512 1 1
2022-09-08 8-K CURRENT REPORT 8.01 0001213900-22-054868 001-35813 221234419 34 200335 1 1
2022-08-10 10-Q QUARTERLY REPORT 0001213900-22-046399 001-35813 221152412 34 3351561 1 1
2022-08-10 4 FORM 4 SUBMISSION 0001209191-22-045207 8790
2022-08-01 4 FORM 4 SUBMISSION 0001209191-22-043772 4892
2022-08-01 4 FORM 4 SUBMISSION 0001209191-22-043771 4883
2022-08-01 4 FORM 4 SUBMISSION 0001209191-22-043770 4990
2022-08-01 4 FORM 4 SUBMISSION 0001209191-22-043769 6600
2022-08-01 4 FORM 4 SUBMISSION 0001209191-22-043768 8328
2022-08-01 4 FORM 4 SUBMISSION 0001209191-22-043767 4945
2022-08-01 4 FORM 4 SUBMISSION 0001209191-22-043766 5267
2022-08-01 4 FORM 4 SUBMISSION 0001209191-22-043765 4976
2022-08-01 4 FORM 4 SUBMISSION 0001209191-22-043764 5019
2022-07-12 S-8 REGISTRATION STATEMENT 0001213900-22-038903 333-266105 221079633 33 86889
2022-07-07 8-K CURRENT REPORT 8.01,9.01 0001213900-22-037750 001-35813 221070657 34 219282 1 1
2022-06-30 8-K ea162323-8k_oramedpharma.htm 5.07 0001213900-22-036294 001-35813 221058204 34 213981 1 1
2022-06-02 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-22-030956 001-35813 22991222 34 1947238
2022-05-12 10-Q QUARTERLY REPORT 0001213900-22-026004 001-35813 22918840 34 3200384 1 1
2022-05-10 4/A xslF345X03/ownership.xml 0001213900-22-025289 5345
2022-05-10 4 xslF345X03/ownership.xml 0001213900-22-025288 4536
2022-05-03 4 xslF345X03/ownership.xml 0001213900-22-023728 7254
2022-04-04 3 xslF345X02/ownership.xml 0001213900-22-017963 3047
2022-04-04 8-K CURRENT REPORT 5.02 0001213900-22-017667 001-35813 22800436 34 201223 1 1
2022-03-30 10-QT TRANSITION REPORT 0001213900-22-016230 001-35813 22787372 34 2975116 1 1
2022-03-22 4 xslF345X03/ownership.xml 0001213900-22-014283 4537
2022-02-28 8-K CURRENT REPORT 5.03 0001213900-22-009794 001-35813 22690926 34 208164 1 1
2022-02-22 4 OWNERSHIP DOCUMENT 0001213900-22-008755 8596
2022-02-15 4/A xslF345X03/ownership.xml 0001213900-22-007951 5349
2022-02-14 4 xslF345X03/ownership.xml 0001213900-22-007695 4883
2022-01-12 8-K CURRENT REPORT 8.01,9.01 0001213900-22-001660 001-35813 22525729 34 234806 1 1
2022-01-11 4 xslF345X03/ownership.xml 0001213900-22-001617 7323
2022-01-11 3 xslF345X02/ownership.xml 0001213900-22-001616 3079
2022-01-11 4/A xslF345X03/ownership.xml 0001213900-22-001613 11042
2022-01-11 10-Q QUARTERLY REPORT 0001213900-22-001563 001-35813 22524446 34 3243849 1 1
2022-01-05 4 xslF345X03/ownership.xml 0001213900-22-000822 8219
2022-01-05 4 xslF345X03/ownership.xml 0001213900-22-000820 7244
2022-01-05 4 xslF345X03/ownership.xml 0001213900-22-000818 10571
2022-01-05 4 xslF345X03/ownership.xml 0001213900-22-000816 7281
2022-01-05 4 xslF345X03/ownership.xml 0001213900-22-000814 7350
2022-01-05 4 xslF345X03/ownership.xml 0001213900-22-000810 7242
2022-01-05 4 xslF345X03/ownership.xml 0001213900-22-000807 7262
2022-01-05 4 xslF345X03/ownership.xml 0001213900-22-000805 7296
2022-01-05 4 xslF345X03/ownership.xml 0001213900-22-000802 11084
2021-12-30 4 xslF345X03/ownership.xml 0001213900-21-068231 6633
2021-12-30 4 xslF345X03/ownership.xml 0001213900-21-068230 4853
2021-12-17 4 xslF345X03/ownership.xml 0001213900-21-066053 4884
2021-12-08 8-K CURRENT REPORT 8.01 0001213900-21-064085 001-35813 211477666 34 205130 1 1
2021-12-07 8-K CURRENT REPORT 7.01,9.01 0001213900-21-063984 001-35813 211476800 34 6341826 1 1
2021-12-07 4 OWNERSHIP DOCUMENT 0001213900-21-063983 5009
2021-12-07 4/A xslF345X03/ownership.xml 0001213900-21-063945 5514
2021-12-07 4/A xslF345X03/ownership.xml 0001213900-21-063944 5320
2021-11-24 10-K ANNUAL REPORT 0001213900-21-062009 001-35813 211448011 34 7197770 1 1
2021-11-04 424B5 PROSPECTUS SUPPLEMENT 0001213900-21-056807 333-257926 211381211 33 215686
2021-11-04 8-K CURRENT REPORT 1.01,9.01 0001213900-21-056803 001-35813 211381158 34 295731
2021-10-29 8-K CURRENT REPORT 8.01 0001213900-21-055258 001-35813 211360802 34 16937
2021-10-15 5 OWNERSHIP DOCUMENT 0001213900-21-053085 6555
2021-09-20 4 xslF345X03/ownership.xml 0001213900-21-048832 4540
2021-09-02 SC 13D/A AMENDMENT NO. 5 TO SCHEDULE 13D 0001213900-21-046415 005-79895 211233898 34 49765
2021-09-02 4 OWNERSHIP DOCUMENT 0001213900-21-046413 7627
2021-09-02 4 xslF345X03/ownership.xml 0001213900-21-046411 4841
2021-09-02 4 xslF345X03/ownership.xml 0001213900-21-046410 4835
2021-09-02 4 xslF345X03/ownership.xml 0001213900-21-046408 4805
2021-09-02 4 xslF345X03/ownership.xml 0001213900-21-046407 4854
2021-09-01 8-K CURRENT REPORT 1.01,1.02,9.01 0001213900-21-046043 001-35813 211228854 34 415968
2021-09-01 424B5 PROSPECTUS SUPPLEMENT 0001213900-21-046040 333-257926 211228832 33 235942
2021-08-31 8-K CURRENT REPORT 5.07 0001213900-21-045898 001-35813 211227166 34 42599
2021-08-13 424B7 424B7 0001213900-21-042536 333-252696 211173240 33 32709
2021-08-11 4 OWNERSHIP DOCUMENT 0001213900-21-041712 25051
2021-08-11 4 OWNERSHIP DOCUMENT 0001213900-21-041711 5367
2021-08-06 4 xslF345X03/ownership.xml 0001213900-21-040761 7953
2021-08-05 8-K CURRENT REPORT 7.01,9.01 0001213900-21-040394 001-35813 211146235 34 5613382
2021-08-04 3 xslF345X02/ownership.xml 0001213900-21-040317 3107
2021-08-02 8-K CURRENT REPORT 8.01 0001213900-21-039829 001-35813 211136400 34 18216
2021-07-28 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-21-039099 001-35813 211122888 34 1289786
2021-07-26 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-07-26 16:30:00 9999999995-21-002920 333-257926 211115782 33 1923
2021-07-22 CORRESP filename1.htm 0001213900-21-038057 34367
2021-07-21 UPLOAD filename1.pdf 0000000000-21-009008 40305
2021-07-16 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-21-037238 001-35813 211095629 34 667577
2021-07-15 S-3 REGISTRATION STATEMENT 0001213900-21-037095 333-257926 211093266 33 467320
2021-07-15 8-K CURRENT REPORT 1.01,5.03,8.01,9.01 0001213900-21-037056 001-35813 211092858 34 383283
2021-07-14 10-Q QUARTERLY REPORT 0001213900-21-036889 001-35813 211090506 34 3106520 1
2021-07-08 3 OWNERSHIP DOCUMENT 0001213900-21-036191 3083
2021-06-16 8-K CURRENT REPORT 1.01,9.01 0001213900-21-032720 001-35813 211021727 34 290161
2021-06-16 424B5 PROSPECTUS SUPPLEMENT 0001213900-21-032714 333-236194 211021596 33 250996
2021-06-16 S-3MEF REGISTRATION STATEMENT 0001213900-21-032645 333-257128 211020616 33 94913
2021-05-25 8-K CURRENT REPORT 5.02 0001213900-21-029048 001-35813 21960600 34 19356
2021-05-10 8-K REPORT OF FOREIGN PRIVATE ISSUER 5.02 0001213900-21-025365 001-35813 21907382 34 16651
2021-04-13 10-Q QUARTERLY REPORT 0001213900-21-021393 001-35813 21823300 34 2529612 1
2021-03-23 8-K CURRENT REPORT 8.01 0001213900-21-017117 001-35813 21763159 34 19146
2021-03-19 8-K CURRENT REPORT 1.01,7.01,8.01,9.01 0001213900-21-016531 001-35813 21756670 34 12013443
2021-03-02 4 xslF345X03/ownership.xml 0001213900-21-012894 8278
2021-02-17 4 xslF345X03/ownership.xml 0001213900-21-010094 5455
2021-02-10 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-02-10 09:00:00 9999999995-21-000563 333-252696 21616442 33 1922
2021-02-09 SC 13G/A AMENDMENT TO FORM SC 13G 0001213900-21-007730 005-79895 21606257 34 89866
2021-02-09 UPLOAD filename1.pdf 0000000000-21-001651 40423
2021-02-09 CORRESP filename1.htm 0001213900-21-007712 31604
2021-02-08 4 xslF345X03/ownership.xml 0001213900-21-007501 5495
2021-02-08 4 xslF345X03/ownership.xml 0001213900-21-007499 5493
2021-02-08 4 xslF345X03/ownership.xml 0001213900-21-007497 5483
2021-02-08 4 xslF345X03/ownership.xml 0001213900-21-007494 5526
2021-02-04 8-K CURRENT REPORT 7.01 0001213900-21-006805 001-35813 21591903 34 17220
2021-02-03 S-3 REGISTRATION STATEMENT 0001213900-21-006524 333-252696 21587304 33 255629
2021-01-14 10-Q QUARTERLY REPORT 0001213900-21-002235 001-35813 21528838 34 2266066 1
2020-12-02 8-K CURRENT REPORT 8.01 0001213900-20-040364 001-35813 201362462 34 20545
2020-12-01 8-K CURRENT REPORT 1.01,9.01 0001213900-20-040263 001-35813 201361718 34 339301
2020-12-01 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-040248 333-236194 201361627 33 256287
2020-11-24 10-K ANNUAL REPORT 0001213900-20-038924 001-35813 201339934 34 5061209 1
2020-10-22 8-K CURRENT REPORT 7.01,9.01 0001213900-20-032805 001-35813 201254990 34 8077650
2020-09-18 8-K CURRENT REPORT 1.01,9.01 0001213900-20-027361 001-35813 201184065 34 596802
2020-09-09 8-K CURRENT REPORT 1.01,9.01 0001213900-20-025857 001-35813 201166668 34 767739
2020-08-27 8-K CURRENT REPORT 1.01 0001213900-20-024016 001-35813 201143284 34 18648
2020-08-11 S-8 FORM S-8 0001213900-20-021429 333-244380 201092964 33 93263
2020-08-04 8-K FORM 8-K 5.02,5.07,8.01,9.01 0001213900-20-020031 001-35813 201071101 34 51020
2020-07-15 8-K CURRENT REPORT 8.01 0001213900-20-017505 001-35813 201028362 34 20737
2020-07-07 10-Q QUARTERLY REPORT 0001213900-20-016864 001-35813 201016232 34 1992244 1
2020-06-30 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-20-016305 001-35813 201002425 34 3225519
2020-06-16 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-20-015109 001-35813 20966766 34 542013
2020-05-01 CT ORDER filename1.pdf 20200501,20200501 9999999997-20-002360 001-35813 20838429 34 124430
2020-05-01 CT ORDER filename1.pdf 20200501,20200501 9999999997-20-002359 001-35813 20838427 34 124856
2020-04-09 8-K CURRENT REPORT 8.01 0001213900-20-008913 001-35813 20784960 34 21181
2020-04-06 10-Q QUARTERLY REPORT 0001213900-20-008653 001-35813 20777464 34 2101139 1
2020-03-02 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-005116 333-236194 20675384 33 308754
2020-02-28 8-K CURRENT REPORT 1.01,9.01 0001213900-20-005018 001-35813 20668040 34 417285
2020-02-26 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-004816 333-236194 20655815 33 302085
2020-02-26 8-K CURRENT REPORT 8.01 0001213900-20-004778 001-35813 20653346 34 24899
2020-02-14 SC 13G/A AMENDMENT TO FORM SC 13G 0001387131-20-001660 005-79895 20616243 34 130080
2020-02-11 SC 13G SCHEDULE 13G 0001213900-20-003270 005-79895 20595138 34 92275
2020-02-10 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-02-10 14:00:00 9999999995-20-000309 333-236194 20593702 33 1922
2020-02-10 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-003130 333-236194 20593099 33 277177
2020-02-06 CORRESP filename1.htm 0001213900-20-002759 12401
2020-02-04 UPLOAD filename1.pdf 0000000000-20-001091 46209
2020-01-31 S-3 REGISTRATION STATEMENT 0001213900-20-002261 333-236194 20565176 33 327536
2020-01-21 SC 13G/A SABBY 13G-A ORMP 1.21.20 0001535610-20-000050 005-79895 20536113 34 13458
2020-01-14 4 OWNERSHIP DOCUMENT 0001213900-20-000993 5458
2020-01-14 4 OWNERSHIP DOCUMENT 0001213900-20-000991 5447
2020-01-14 4 OWNERSHIP DOCUMENT 0001213900-20-000989 5451
2020-01-14 4 OWNERSHIP DOCUMENT 0001213900-20-000988 5468
2020-01-14 4 OWNERSHIP DOCUMENT 0001213900-20-000985 5482
2020-01-14 4 OWNERSHIP DOCUMENT 0001213900-20-000984 5525
2020-01-14 4 OWNERSHIP DOCUMENT 0001213900-20-000983 5460
2020-01-09 10-Q QUARTERLY REPORT 0001213900-20-000631 001-35813 20518169 34 1963876 1
2019-12-11 3 xslF345X02/ownership.xml 0001213900-19-025901 3614
2019-12-06 8-K CURRENT REPORT 5.02 0001213900-19-025444 001-35813 191271280 34 17533
2019-11-27 10-K ANNUAL REPORT 0001213900-19-024940 001-35813 191258255 34 6341626 1
2019-11-12 8-K CURRENT REPORT 8.01 0001213900-19-022717 001-35813 191206001 34 27023
2019-10-23 S-8 REGISTRATION STATEMENT 0001213900-19-020923 333-234303 191164156 33 139144
2019-09-16 4 xslF345X03/ownership.xml 0001213900-19-018200 7571
2019-09-16 4 xslF345X03/ownership.xml 0001213900-19-018199 7794
2019-09-16 4 xslF345X03/ownership.xml 0001213900-19-018198 7808
2019-09-16 4 xslF345X03/ownership.xml 0001213900-19-018197 7888
2019-09-16 4 xslF345X03/ownership.xml 0001213900-19-018196 5414
2019-09-16 3 xslF345X02/ownership.xml 0001213900-19-018195 3647
2019-09-11 4 OWNERSHIP DOCUMENT 0001213900-19-017770 7863
2019-09-05 424B5 PROSPECTUS SUPPLEMENT 0001213900-19-017289 333-215525 191077621 33 193088
2019-09-05 8-K CURRENT REPORT 1.01,5.02,5.07,9.01 0001213900-19-017287 001-35813 191077587 34 342051
2019-08-21 8-K FORM 8-K 5.02 0001213900-19-016472 001-35813 191043791 34 26624
2019-08-06 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-19-014679 001-35813 191001326 34 545396
2019-07-29 8-K CURRENT REPORT 5.02 0001213900-19-013773 001-35813 19979292 34 23904
2019-07-19 3 xslF345X02/ownership.xml 0001213900-19-013179 4276
2019-07-18 4 xslF345X03/ownership.xml 0001213900-19-013085 10781
2019-07-15 4 OWNERSHIP DOCUMENT 0001213900-19-012780 6365
2019-07-10 10-Q QUARTERLY REPORT 0001213900-19-012456 001-35813 19950050 34 3532596 1
2019-07-01 8-K FORM 8-K 5.02 0001213900-19-011856 001-35813 19932931 34 18792
2019-06-27 4 xslF345X03/ownership.xml 0001213900-19-011646 5506
2019-06-05 3 xslF345X02/ownership.xml 0001213900-19-010104 3069
2019-05-16 8-K CURRENT REPORT 5.02 0001213900-19-009033 001-35813 19833228 34 16916
2019-04-16 4 xslF345X03/ownership.xml 0001213900-19-006513 5222
2019-04-16 8-K CURRENT REPORT 1.02 0001213900-19-006512 001-35813 19751506 34 14102
2019-04-12 4 xslF345X03/ownership.xml 0001213900-19-006288 5163
2019-04-10 10-Q QUARTERLY REPORT 0001213900-19-006121 001-35813 19742309 34 2458066 1
2019-03-28 8-K CURRENT REPORT 5.02 0001213900-19-005120 001-35813 19712634 34 13426
2019-03-13 8-K CURRENT REPORT 8.01 0001213900-19-004051 001-35813 19678817 34 13664
2019-02-28 4 xslF345X03/ownership.xml 0001213900-19-003338 5466
2019-02-28 4 xslF345X03/ownership.xml 0001213900-19-003337 5420
2019-02-28 4 xslF345X03/ownership.xml 0001213900-19-003334 5406
2019-02-28 4 xslF345X03/ownership.xml 0001213900-19-003333 5492
2019-02-13 SC 13G/A AMENDED FORM SC 13G 0001387131-19-001135 005-79895 19597384 34 122082
2019-01-14 10-Q QUARTERLY REPORT 0001213900-19-000691 001-35813 19525672 34 2714439 1
2019-01-07 SC 13G/A SABBY 13G-A ORMP 1.07.19 0001535610-19-000041 005-79895 19512349 34 13440
2018-12-14 8-K CURRENT REPORT 8.01 0001213900-18-017333 001-35813 181234582 34 26827
2018-11-28 10-K ANNUAL REPORT 0001213900-18-016666 001-35813 181206390 34 6331088 1
2018-11-20 3 xslF345X02/ownership.xml 0001213900-18-016314 3069
2018-11-08 8-K CURRENT REPORT 5.02 0001213900-18-015178 001-35813 181170476 34 15599
2018-09-17 8-K CURRENT REPORT 8.01 0001213900-18-012630 001-35813 181072830 34 25898
2018-08-30 8-K CURRENT REPORT 5.07 0001213900-18-011939 001-35813 181047667 34 39898
2018-08-13 4 xslF345X03/ownership.xml 0001213900-18-010829 6849
2018-07-30 DEF 14A def14a2018_oramed.htm 0001213900-18-009875 001-35813 18978549 34 504297
2018-07-20 SC 13D/A AMENDMENT NO. 1 TO SCHEDULE 13D 0001213900-18-009488 005-79895 18963151 34 78008
2018-07-20 SC 13D/A AMENDMENT NO. 4 TO SCHEDULE 13D 0001213900-18-009486 005-79895 18963092 34 74551
2018-07-13 SC 13G ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-18-003118 005-79895 18951920 34 133018
2018-07-12 10-Q QUARTERLY REPORT 0001213900-18-009132 001-35813 18951059 34 2263341 1
2018-07-12 4 xslF345X03/ownership.xml 0001213900-18-009128 6352
2018-07-12 SC 13G d7941740_13-g.htm 0000919574-18-004721 005-79895 18950928 34 113131
2018-07-05 424B5 PROSPECTUS SUPPLEMENT 0001213900-18-008784 333-215525 18940939 33 343129
2018-07-05 8-K CURRENT REPORT 1.01,9.01 0001213900-18-008780 001-35813 18940682 34 492542
2018-07-03 SC 13G SABBY 13G ORMP 7.03.18 0001535610-18-000095 005-79895 18934959 34 13438
2018-05-07 4 OWNERSHIP DOCUMENT 0001213900-18-005618 5427
2018-04-16 CT ORDER filename1.pdf 20180416,20180416 9999999997-18-004782 001-35813 18755836 34 14925
2018-04-10 4 OWNERSHIP DOCUMENT 0001213900-18-004250 5442

Latest XBRL company facts

One latest value per concept from companyfacts (621 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 43.49M 2026-11-11 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
dei EntityPublicFloat Entity Public Float USD 77.66M 2025-06-30 2025 FY 10-K 2026-03-26 0001213900-26-034835
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 2.06M 2025-01-01 2025-12-31 DEF 14A 2026-08-03 0001213900-26-084609
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.02M 2025-01-01 2025-12-31 DEF 14A 2026-08-03 0001213900-26-084609
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 4.80M 2025-01-01 2025-12-31 DEF 14A 2026-08-03 0001213900-26-084609
ecd PeoTotalCompAmt PeoTotalCompAmt USD 4.77M 2025-01-01 2025-12-31 DEF 14A 2026-08-03 0001213900-26-084609
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 118 2025-01-01 2025-12-31 DEF 14A 2026-08-03 0001213900-26-084609
invest InvestmentInterestRateRangeEnd Investment Interest Rate Range End pure 0.01 2014-09-01 2015-02-28 2015 Q2 10-Q 2015-04-03 0001178913-15-001193
invest InvestmentInterestRateRangeStart Investment Interest Rate Range Start pure 0.009 2014-09-01 2015-02-28 2015 Q2 10-Q 2015-04-03 0001178913-15-001193
invest InvestmentWarrantsExercisePrice Investment Warrants, Exercise Price USD 7.25 2017-09-01 2018-08-31 2018 FY 10-K 2018-11-28 0001213900-18-016666
srt LongTermDebtAverageRatePaid LongTermDebtAverageRatePaid pure 0.009 2020-09-01 2021-08-31 2021 FY 10-K 2021-11-24 0001213900-21-062009
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 7.29M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 1.61M 2023-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap AccountsPayableAndOtherAccruedLiabilities Accounts Payable and Other Accrued Liabilities USD 2.77M 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095397
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 392,289 2013-08-31 2013 FY 10-K 2013-11-27 0001178913-13-003442
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 125,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap AccountsPayableCurrentAndNoncurrent Accounts Payable USD 551,000 2023-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap AccountsPayableOtherCurrent Accounts Payable, Other, Current USD 47,252 2014-05-31 2014 Q3 10-Q 2014-07-14 0001178913-14-002290
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 333,719 2013-05-31 2013 Q3 10-Q 2013-07-17 0001178913-13-002087
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD -23,559 2002-04-12 2014-02-28 2014 Q2 10-Q 2014-04-10 0001178913-14-001274
us-gaap AccruedIncomeTaxes Accrued Income Taxes USD 3.20M 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 5.55M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 765,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 814,000 2018-08-31 2018 FY 10-K 2018-11-28 0001213900-18-016666
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 134,000 2015-08-31 2015 FY 10-K 2015-11-25 0001213900-15-009096
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 702,000 2018-08-31 2019 FY 10-K 2019-11-27 0001213900-19-024940
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 318.73M 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065678
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 327.12M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap AdjustmentForAmortization Amortization USD 1.70M 2024-09-23 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap AdjustmentOfWarrantsGrantedForServices Adjustment of Warrants Granted for Services USD 1.50M 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071222
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 1.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 108,000 2002-04-12 2007-08-31 2014 Q2 10-Q 2014-04-10 0001178913-14-001274
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 18,991 2002-04-12 2007-08-31 2014 Q2 10-Q 2014-04-10 0001178913-14-001274
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition USD 36,427 2013-09-01 2014-05-31 2014 Q3 10-Q 2014-07-14 0001178913-14-002290
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.47M 2013-09-01 2014-08-31 2014 FY 10-K 2014-11-14 0001178913-14-003555
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 1.00M 2013-09-01 2014-05-31 2014 Q3 10-Q 2014-07-14 0001178913-14-002290
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 918,000 2012-09-01 2013-08-31 2014 FY 10-K 2014-11-14 0001178913-14-003555
us-gaap AdvancesForGasExplorationDevelopmentAndProductionAmount Advances for Gas Exploration, Development and Production Amount USD 15.00M 2022-11-13 2023 Q3 10-Q 2023-11-09 0001213900-23-085310
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 469,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 108,000 2002-04-12 2014-02-28 2014 Q2 10-Q 2014-04-10 0001178913-14-001274
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 1.85M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap AreaOfLand Area of Land sqm 264 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap Assets Assets USD 400.92M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap AssetsCurrent Assets, Current USD 57.38M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 1.52M 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap AssetsNoncurrent Assets, Noncurrent USD 343.54M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 3.31M 2022-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 9.26M 2021-02-28 2021 Q2 10-Q 2021-04-13 0001213900-21-021393
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 632,000 2018-08-31 2018 FY 10-K 2018-11-28 0001213900-18-016666
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 367,000 2024-03-31 2024 Q1 10-Q 2024-05-09 0001213900-24-041364
us-gaap AvailableForSaleSecuritiesFairValueDisclosure Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) USD 1.06M 2012-11-30 2013 Q1 10-Q 2012-12-26 0001178913-12-003519
us-gaap AvailableforsaleSecuritiesGrossUnrealizedGainLoss1 Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) USD -43,000 2017-09-01 2018-05-31 2018 Q3 10-Q 2018-07-12 0001213900-18-009132
us-gaap AvailableForSaleSecuritiesGrossUnrealizedGains Available-for-sale Securities, Gross Unrealized Gain USD -1,000 2016-09-01 2017-05-31 2017 Q3 10-Q 2017-07-06 0001213900-17-007202
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLoss Available-for-sale Securities, Gross Unrealized Loss USD -4,000 2016-09-01 2016-11-30 2017 Q1 10-Q 2017-01-11 0001213900-17-000252
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 180,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044193
us-gaap BusinessCombinationPriceOfAcquisitionExpected BusinessCombinationPriceOfAcquisitionExpected USD 373,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076668
us-gaap BusinessDevelopment Business Development USD 1.12M 2002-04-12 2013-08-31 2013 FY 10-K 2013-11-27 0001178913-13-003442
us-gaap BusinessExitCosts1 Business Exit Costs USD 3.06M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap CarryingValueOfSecuritiesSoldUnderRepurchaseAgreementsAndDepositsReceivedForSecuritiesLoaned Carrying Value of Securities Sold under Repurchase Agreements and Deposits Received for Securities Loaned USD 99.55M 2023-08-08 2023 Q3 10-Q 2023-11-09 0001213900-23-085310
us-gaap Cash Cash USD 6.50M 2026-03-31 2026 Q1 10-Q 2026-05-19 0001213900-26-059112
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 15.24M 2026-06-30 2026 Q2 10-Q 2026-08-10 0001213900-26-087361
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 2.60M 2019-09-01 2020-02-29 2020 Q2 10-Q 2020-04-06 0001213900-20-008653
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 28.93M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -17.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 54.42M 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/warrants 0.5 2012-08-31 2012 FY 10-K 2012-12-12 0001178913-12-003413
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 4.13 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 20,000 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 3.41M 2020-08-31 2020 FY 10-K 2020-11-24 0001213900-20-038924
us-gaap CommonStockConvertibleConversionPriceDecrease Common Stock, Convertible, Conversion Price, Decrease USD/shares 0.45 2026-02-24 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap CommonStockDividendsPerShareCashPaid Common Stock, Dividends, Per Share, Cash Paid USD/shares 0.25 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap CommonStockOtherSharesOutstanding Common Stock, Other Shares, Outstanding shares 1.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.012 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 60.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 43.24M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 43.24M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap CommonStockValue Common Stock, Value, Issued USD 519,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap CommonUnitIssued Common Unit, Issued shares 1.89M 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065678
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 22.24M 2020-09-01 2021-08-31 2021 FY 10-K 2021-11-24 0001213900-21-062009
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD -751,000 2020-09-01 2021-08-31 2021 FY 10-K 2021-11-24 0001213900-21-062009
us-gaap ContractualObligation Contractual Obligation USD 29.49M 2026-06-30 2026 Q2 10-Q 2026-08-10 0001213900-26-087361
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 2.00M 2020-08-21 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 1.51M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 2.00M 2025-12-31 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap ContributionOfProperty Contribution of Property USD 18,991 2002-04-12 2014-02-28 2014 Q2 10-Q 2014-04-10 0001178913-14-001274
us-gaap ConvertibleDebt Convertible Debt USD 25.00M 2024-10-07 2024 Q3 10-Q 2024-11-07 0001213900-24-095397
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 3.00M 2025-11-14 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap CostMethodInvestments Cost Method Investments USD 1,000 2021-02-28 2021 Q2 10-Q 2021-04-13 0001213900-21-021393
us-gaap CostOfRevenue Cost of Revenue USD 1.99M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap CostsAndExpensesRelatedParty Costs and Expenses, Related Party USD 331,000 2022-10-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 2.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 918,000 2012-09-01 2013-08-31 2014 FY 10-K 2014-11-14 0001178913-14-003555
us-gaap DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 Debt Conversion, Converted Instrument, Warrants or Options Issued shares 917,809 2002-04-12 2013-02-28 2013 Q2 10-Q 2013-04-11 0001178913-13-001073
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount ILS 100.00M 2026-03-31 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 101.88M 2023-09-21 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap DebtInstrumentFairValue Debt Instrument, Fair Value Disclosure USD 4.64M 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap DebtInstrumentInterestRateStatedPercentageRateRangeMaximum Debt Instrument, Interest Rate, Stated Percentage Rate Range, Maximum (Deprecated 2016-01-31) pure 0.01 2014-09-01 2015-05-31 2015 Q3 10-Q 2015-07-01 0001213900-15-004892
us-gaap DebtInstrumentInterestRateStatedPercentageRateRangeMinimum Debt Instrument, Interest Rate, Stated Percentage Rate Range, Minimum (Deprecated 2016-01-31) pure 0.009 2014-09-01 2015-05-31 2015 Q3 10-Q 2015-07-01 0001213900-15-004892
us-gaap DebtInstrumentPeriodicPaymentInterest Debt Instrument, Periodic Payment, Interest USD 2.50M 2020-09-01 2021-05-31 2021 Q3 10-Q 2021-07-14 0001213900-21-036889
us-gaap DebtInstrumentRepaidPrincipal DebtInstrumentRepaidPrincipal USD 2.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap DebtorReorganizationItemsRevaluationOfAssetsAndLiabilities Debtor Reorganization Items, Revaluation of Assets and Liabilities USD 549,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap DebtSecuritiesGainLoss Debt Securities, Gain (Loss) USD 43,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap DebtSecuritiesNoncurrent Debt Securities, Noncurrent USD 3.74M 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage pure 0.03 2021-09-01 2023 Q3 10-Q 2023-11-09 0001213900-23-085310
us-gaap DeferredCostsCurrentAndNoncurrent Deferred Costs USD 11.01M 2020-02-29 2020 Q2 10-Q 2020-04-06 0001213900-20-008653
us-gaap DeferredIncome Deferred Income USD 857,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap DeferredIncomeCurrent Deferred Income, Current USD 1.35M 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap DeferredIncomeNoncurrent Deferred Income, Noncurrent USD 1.27M 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap DeferredIncomeRevenueRecognized DeferredIncomeRevenueRecognized USD 975,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-10 0001213900-26-087361
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 42.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 50.14M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap DeferredOtherTaxExpenseBenefit Deferred Other Tax Expense (Benefit) USD 42.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap DeferredRevenue Deferred Revenue USD 674,000 2023-03-31 2023 Q1 10-Q 2023-05-11 0001213900-23-038593
us-gaap DeferredRevenueAdditions Deferred Revenue, Additions USD 3.00M 2018-09-01 2019-08-31 2019 FY 10-K 2019-11-27 0001213900-19-024940
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 1.34M 2022-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 4.00M 2024-03-31 2024 Q1 10-Q 2024-05-09 0001213900-24-041364
us-gaap DeferredRevenueRefundPayments1 Deferred Revenue, Refund Payments USD 24,000 2016-09-01 2017-08-31 2018 FY 10-K 2018-11-28 0001213900-18-016666
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 20.38M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 1.00M 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap DeferredTaxAssetsInvestments Deferred Tax Assets, Investments USD 2.61M 2023-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 27.31M 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 134,000 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 3,194 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 28.38M 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 7.91M 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 24,000 2014-09-01 2015-08-31 2015 FY 10-K 2015-11-25 0001213900-15-009096
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.15 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap DepositAssets Deposit Assets USD 95.28M 2023-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap DepositLiabilitiesAccruedInterest Deposit Liabilities, Accrued Interest USD 875,000 2023-09-21 2024 Q1 10-Q 2024-05-09 0001213900-24-041364
us-gaap Deposits Deposits USD -11.04M 2016-08-31 2016 FY 10-K 2016-11-25 0001213900-16-018954
us-gaap DepositsAssets Deposits Assets USD 13.54M 2018-08-31 2019 FY 10-K 2019-11-27 0001213900-19-024940
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 10.98M 2025-12-31 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap Depreciation Depreciation USD 91,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 3,000 2015-09-01 2016-05-31 2016 Q3 10-Q 2016-07-06 0001213900-16-014744
us-gaap DerivativeFixedInterestRate Derivative, Fixed Interest Rate pure 0.009 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 45,000 2012-09-01 2013-08-31 2014 FY 10-K 2014-11-14 0001178913-14-003555
us-gaap DerivativeGainOnDerivative Derivative, Gain on Derivative USD 44,000 2012-09-01 2013-08-31 2015 FY 10-K 2015-11-25 0001213900-15-009096
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 637,182 2012-08-31 2013 Q3 10-Q 2013-07-17 0001178913-13-002087
us-gaap DerivativeLossOnDerivative Derivative, Loss on Derivative USD 143,000 2011-09-01 2012-08-31 2014 FY 10-K 2014-11-14 0001178913-14-003555
us-gaap DividendIncomeEquitySecuritiesOperating Dividend Income, Equity Securities, Operating USD 824,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap DividendsCommonStockCash Dividends, Common Stock, Cash USD 10.87M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap DividendsPayableCurrent Dividends Payable, Current USD 243,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 123,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap DueFromJointVenturesCurrent Due from Joint Ventures, Current USD 450,844 2011-08-31 2012 FY 10-K 2012-12-12 0001178913-12-003413
us-gaap DueFromOtherRelatedPartiesCurrent Due from Other Related Parties, Current USD 330,000 2014-08-31 2015 FY 10-K 2015-11-25 0001213900-15-009096
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 330,000 2014-08-31 2015 FY 10-K 2015-11-25 0001213900-15-009096
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 58,000 2021-05-31 2021 Q3 10-Q 2021-07-14 0001213900-21-036889
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 3.28 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares 0.31 2021-09-01 2021-12-31 2021 Q2 10-QT 2022-03-30 0001213900-22-016230
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 3.17 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.15 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.088 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 114,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap EffectiveIncomeTaxRateReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Percent pure 0.5 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.8 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlementsOther Effective Income Tax Rate Reconciliation, Tax Settlement, Other, Percent pure 0.5 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 9,000 2021-09-01 2021-12-31 2021 Q2 10-QT 2022-03-30 0001213900-22-016230
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -65,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 25,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 382,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap EmployeeRelatedLiabilitiesCurrentAndNoncurrent Employee-related Liabilities USD 29,000 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095397
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 707,000 2023-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 122,000 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap EmployeeStockOwnershipPlanESOPCompensationExpense Employee Stock Ownership Plan (ESOP), Compensation Expense USD 89,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap EquityIssuancePerShareAmount Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) USD 10 2013-09-01 2014-05-31 2014 Q3 10-Q 2014-07-14 0001178913-14-002290
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.017 2021-08-31 2021 FY 10-K 2021-11-24 0001213900-21-062009
us-gaap EquityMethodInvestments Equity Method Investments USD 640,000 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044193
us-gaap EquityMethodInvestmentsFairValueDisclosure Equity Method Investments, Fair Value Disclosure USD 4,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap EquitySecuritiesFvNi Equity Securities, FV-NI USD 24.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap EquitySecuritiesFVNINoncurrent EquitySecuritiesFVNINoncurrent USD 4.42M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap ExcessStockSharesIssued Excess Stock, Shares Issued shares 273,997 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap ExciseAndSalesTaxes Excise and Sales Taxes USD 6,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 36.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2015-09-01 2016-05-31 2016 Q3 10-Q 2016-07-06 0001213900-16-014744
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.018 2015-09-01 2016-05-31 2016 Q3 10-Q 2016-07-06 0001213900-16-014744
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings (Deprecated 2012-01-31) USD -197,412 2010-09-01 2011-08-31 2012 FY 10-K 2012-12-12 0001178913-12-003413
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings USD 52,343 2012-09-01 2013-08-31 2013 FY 10-K 2013-11-27 0001178913-13-003442
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease) USD 328,950 2012-09-01 2013-08-31 2013 FY 10-K 2013-11-27 0001178913-13-003442
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases USD 628,630 2012-09-01 2013-08-31 2013 FY 10-K 2013-11-27 0001178913-13-003442
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 905,237 2012-09-01 2013-08-31 2013 FY 10-K 2013-11-27 0001178913-13-003442
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value USD 27.94M 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances USD 28,000 2012-09-01 2013-08-31 2014 FY 10-K 2014-11-14 0001178913-14-003555
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 637,000 2012-08-31 2014 FY 10-K 2014-11-14 0001178913-14-003555
us-gaap FairValueOptionAggregateDifferencesLongTermDebtInstruments Fair Value, Option, Aggregate Differences, Long-term Debt Instruments USD 3.42M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap FairValueOptionChangesInFairValueGainLoss1 Fair Value, Option, Changes in Fair Value, Gain (Loss) USD -3.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD 3.18M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 565,000 2021-08-31 2021 FY 10-K 2021-11-24 0001213900-21-062009
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 500,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044193
us-gaap ForeignCurrencyTransactionGainBeforeTax Foreign Currency Transaction Gain, before Tax USD 176,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap ForeignCurrencyTransactionGainLossAfterTax ForeignCurrencyTransactionGainLossAfterTax USD -96,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -127,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap ForeignCurrencyTransactionLossBeforeTax Foreign Currency Transaction Loss, before Tax USD 124,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap ForeignIncomeTaxExpenseBenefitContinuingOperations Foreign Income Tax Expense (Benefit), Continuing Operations USD -100,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 13,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 5.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap GainLossOnDispositionOfIntangibleAssets Gain (Loss) on Disposition of Intangible Assets USD 5.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 178.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments Gain (Loss) on Investments, Excluding Other than Temporary Impairments USD 1.03M 2002-04-12 2014-02-28 2014 Q2 10-Q 2014-04-10 0001178913-14-001274
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD 80,000 2013-09-01 2014-08-31 2016 FY 10-K 2016-11-25 0001213900-16-018954
us-gaap GainLossOnSaleOfSecuritiesNet Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) USD 80,000 2013-09-01 2014-08-31 2016 FY 10-K 2016-11-25 0001213900-16-018954
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 8.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap GeneralInsuranceExpense General Insurance Expense USD 162,320 2002-04-12 2013-08-31 2013 FY 10-K 2013-11-27 0001178913-13-003442
us-gaap GrantsReceivable Grants Receivable USD 665,000 2022-09-18 2022 Q3 10-Q 2022-11-10 0001213900-22-071222
us-gaap GrantsReceivableCurrent Grants Receivable, Current USD 78,000 2014-08-31 2015 FY 10-K 2015-11-25 0001213900-15-009096
us-gaap GrossProfit Gross Profit USD 13,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap HeldToMaturitySecurities Debt Securities, Held-to-maturity USD 3.88M 2021-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss USD 2,000 2016-05-31 2016 Q3 10-Q 2016-07-06 0001213900-16-014744
us-gaap HeldToMaturitySecuritiesCurrent Debt Securities, Held-to-maturity, Current USD 1.46M 2024-03-31 2024 Q1 10-Q 2024-05-09 0001213900-24-041364
us-gaap HeldToMaturitySecuritiesFairValue Debt Securities, Held-to-maturity, Fair Value USD 3.22M 2022-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap HeldToMaturitySecuritiesNoncurrent Debt Securities, Held-to-maturity, Noncurrent USD 4.72M 2020-05-31 2020 Q3 10-Q 2020-07-07 0001213900-20-016864
us-gaap IncomeLossAttributableToParent Income (Loss) Attributable to Parent, before Tax USD -37.66M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -8.85M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 179.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -7.07M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD 8.52M 2019-09-01 2020-05-31 2020 Q3 10-Q 2020-07-07 0001213900-20-016864
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 100,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions Income (Loss) from Equity Method Investments, Net of Dividends or Distributions USD 8.59M 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071222
us-gaap IncomeTaxesPaid Income Taxes Paid USD 3.32M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD -2,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 59,898 2013-08-31 2013 FY 10-K 2013-11-27 0001178913-13-003442
us-gaap IncomeTaxExaminationPenaltiesExpense Income Tax Examination, Penalties Expense USD 0 2013-09-01 2014-08-31 2014 FY 10-K 2014-11-14 0001178913-14-003555
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 44.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD 3,194 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap IncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends Effective Income Tax Rate Reconciliation, Deduction, Employee Stock Ownership Plan Dividend, Amount USD 100,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -6.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap IncomeTaxReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Amount USD 878,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -219,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 15.82M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 122,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD -11,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 13,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD -174,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD -13,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD -15,000 2015-09-01 2016-08-31 2018 FY 10-K 2018-11-28 0001213900-18-016666
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 475,000 2013-09-01 2014-08-31 2014 FY 10-K 2014-11-14 0001178913-14-003555
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -28,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD 3.10M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095397
us-gaap IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets Increase (Decrease) in Accounts Receivable and Other Operating Assets USD 560,682 2002-04-12 2013-05-31 2013 Q3 10-Q 2013-07-17 0001178913-13-002087
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -2.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD -9.84M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-19 0001213900-26-059112
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD -675,000 2019-09-01 2019-11-30 2020 Q1 10-Q 2020-01-09 0001213900-20-000631
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -666,000 2023-01-01 2023-03-31 2024 Q1 10-Q 2024-05-09 0001213900-24-041364
us-gaap IncreaseDecreaseInDueFromRelatedPartiesCurrent Increase (Decrease) in Due from Related Parties, Current USD 3.33M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065678
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD 4,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap IncreaseDecreaseInIncomeTaxes Increase (Decrease) in Income Taxes USD 23,210 2002-04-12 2014-02-28 2014 Q2 10-Q 2014-04-10 0001178913-14-001274
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 21,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap IncreaseDecreaseInOperatingLiabilities Increase (Decrease) in Operating Liabilities USD 5,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065678
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD -59,000 2019-09-01 2020-08-31 2020 FY 10-K 2020-11-24 0001213900-20-038924
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -60,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044193
us-gaap IncreaseDecreaseInOtherOperatingCapitalNet Increase (Decrease) in Other Operating Assets and Liabilities, Net USD 25,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065678
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -60,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap IncreaseDecreaseInPensionAndPostretirementObligations Increase (Decrease) in Obligation, Pension and Other Postretirement Benefits USD -5,000 2019-09-01 2020-05-31 2020 Q3 10-Q 2020-07-07 0001213900-20-016864
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -1.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 2,615 2002-04-12 2014-02-28 2014 Q2 10-Q 2014-04-10 0001178913-14-001274
us-gaap IncreaseDecreaseInRestrictedCashForOperatingActivities Increase (Decrease) in Restricted Cash for Operating Activities USD 16,000 2002-04-12 2014-02-28 2014 Q2 10-Q 2014-04-10 0001178913-14-001274
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 1.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap InformationTechnologyAndDataProcessing Information Technology and Data Processing USD 270.00M 2018-12-01 2018-12-11 2022 Q1 10-Q 2022-01-11 0001213900-22-001563
us-gaap InterestBearingDepositsInBanks Interest-bearing Deposits in Banks and Other Financial Institutions USD 11.06M 2020-08-31 2020 FY 10-K 2020-11-24 0001213900-20-038924
us-gaap InterestExpense Interest Expense USD 592,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0001213900-24-041364
us-gaap InterestExpenseDebt Interest Expense, Debt USD 2.57M 2024-01-01 2024-12-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044193
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 853,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap InterestIncomeDepositsWithFinancialInstitutions Interest Income, Deposits with Financial Institutions USD 16.54M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068992
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 4.13M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap InterestIncomeOther Interest Income, Other USD 524,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 2.32M 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-13 0001213900-25-109980
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 11.85M 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095397
us-gaap InvestmentCompanyCommittedCapital Investment Company, Committed Capital USD 75.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement USD 1.00M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065678
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 10,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 93.77M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap InvestmentOwnedBalancePrincipalAmount Investment Owned, Balance, Principal Amount USD 2.50M 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095397
us-gaap Investments Investments USD 25.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap InvestmentsAndOtherNoncurrentAssets Investments and Other Noncurrent Assets USD 7,000 2023-03-31 2023 Q1 10-Q 2023-05-11 0001213900-23-038593
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 25.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures USD 230.63M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 9,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 37,000 2018-09-01 2019-08-31 2019 FY 10-K 2019-11-27 0001213900-19-024940
us-gaap LegalFees Legal Fees USD 850,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 1.79M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five USD 10,000 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071222
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four USD 123,000 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071222
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three USD 210,000 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071222
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two USD 270,000 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071222
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months USD 270,000 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071222
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 402,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 104,000 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 529,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 382,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 389,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 93,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 265,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap Liabilities Liabilities USD 502,688 2012-05-31 2012 Q3 10-Q 2012-07-12 0001178913-12-001916
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 400.92M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap LiabilitiesCurrent Liabilities, Current USD 9.45M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 52.39M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap LiabilitiesOtherThanLongtermDebtNoncurrent Liabilities, Other than Long-term Debt, Noncurrent USD 4.24M 2021-08-31 2021 FY 10-K 2021-11-24 0001213900-21-062009
us-gaap LiabilitiesSubjectToCompromiseEarlyContractTerminationFees Liabilities Subject to Compromise, Early Contract Termination Fees USD 3.41M 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065678
us-gaap LiabilityForUncertainTaxPositionsNoncurrent Liability for Uncertainty in Income Taxes, Noncurrent USD 11,000 2023-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap LicenseCosts License Costs (Deprecated 2018-01-31) USD 558,297 2002-04-12 2013-08-31 2013 FY 10-K 2013-11-27 0001178913-13-003442
us-gaap LoanProcessingFee Loan Processing Fee USD 1.00M 2023-09-21 2024 Q1 10-Q 2024-05-09 0001213900-24-041364
us-gaap LongTermDebt Long-term Debt USD 74.55M 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085310
us-gaap LongTermDebtFairValue Long-term Debt, Fair Value USD 2.08M 2022-01-03 2022 Q3 10-Q 2022-11-10 0001213900-22-071222
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months USD 49.55M 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085310
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 25.00M 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085310
us-gaap LongTermInvestments Long-term Investments USD 30,991 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085310
us-gaap LongTermPurchaseCommitmentAmount Long-term Purchase Commitment, Amount USD 11.58M 2024-09-23 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap MarketableSecurities Marketable Securities USD 110.56M 2023-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 583,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap MarketableSecuritiesGainLoss Marketable Securities, Gain (Loss) USD 6,000 2020-09-01 2021-08-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss USD -1.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 10.80M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 1.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD -918,000 2024-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap MortgagesHeldForSaleFairValueDisclosure Mortgages Held-for-sale, Fair Value Disclosure USD 990.00M 2025-03-24 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -12.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -1.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -2.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 134.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -34,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap NetIncomeLossAttributableToRedeemableNoncontrollingInterest Net Income (Loss) Attributable to Redeemable Noncontrolling Interest USD -1.20M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 134.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD 134.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap NoncashMergerRelatedCosts Noncash Merger Related Costs USD 1.04M 2020-09-01 2021-08-31 2021 FY 10-K 2021-11-24 0001213900-21-062009
us-gaap NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1 Noncash or Part Noncash Acquisition, Other Assets Acquired USD 886,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD 53,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap NoncontrollingInterestInVariableInterestEntity Noncontrolling Interest in Variable Interest Entity USD 1.50M 2021-08-31 2021 FY 10-K 2021-11-24 0001213900-21-062009
us-gaap NoninterestExpenseCommissionExpense Noninterest Expense Commission Expense USD 15,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap NoninterestExpenseDirectorsFees Noninterest Expense Directors Fees USD 100,000 2020-09-01 2021-08-31 2021 FY 10-K 2021-11-24 0001213900-21-062009
us-gaap NoninterestExpenseOfferingCost Noninterest Expense Offering Cost USD 100.00M 2021-09-01 2023 Q3 10-Q 2023-11-09 0001213900-23-085310
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 180.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap NonredeemableNoncontrollingInterest Nonredeemable Noncontrolling Interest USD -1.50M 2021-03-31 2022 Q1 10-Q 2022-05-12 0001213900-22-026004
us-gaap NotesIssued1 Notes Issued USD 5.16M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap NotesPayableCurrent Notes Payable, Current USD 652,000 2025-12-31 2026 Q1 10-Q 2026-05-19 0001213900-26-059112
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 1,000 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap OfficersCompensation Salary and Wage, Officer, Excluding Cost of Good and Service Sold ILS 63,186 2026-01-01 2026 Q1 10-Q 2026-05-19 0001213900-26-059112
us-gaap OperatingExpenses Operating Expenses USD 201,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071222
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -10.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap OperatingLeaseCost Operating Lease, Cost USD 292,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 1.53M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 303,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 1.23M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 1.43M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due ILS 89,000 2015-05-31 2015 Q3 10-Q 2015-07-01 0001213900-15-004892
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 84,000 2021-02-28 2021 Q2 10-Q 2021-04-13 0001213900-21-021393
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 133,000 2021-02-28 2021 Q2 10-Q 2021-04-13 0001213900-21-021393
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 133,000 2021-02-28 2021 Q2 10-Q 2021-04-13 0001213900-21-021393
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 135,000 2021-02-28 2021 Q2 10-Q 2021-04-13 0001213900-21-021393
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 165,000 2021-02-28 2021 Q2 10-Q 2021-04-13 0001213900-21-021393
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 650,000 2021-02-28 2021 Q2 10-Q 2021-04-13 0001213900-21-021393
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.063 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 3.39M 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 19.39M 2020-08-31 2020 FY 10-K 2020-11-24 0001213900-20-038924
us-gaap OtherAccountsPayableAndAccruedLiabilities Other Accounts Payable and Accrued Liabilities USD 227,000 2017-08-31 2018 FY 10-K 2018-11-28 0001213900-18-016666
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 474,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap OtherAccruedLiabilitiesCurrentAndNoncurrent Other Accrued Liabilities USD 3.75M 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap OtherAccruedLiabilitiesNoncurrent Other Accrued Liabilities, Noncurrent USD 605,000 2023-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap OtherAdditionalCapital Other Additional Capital USD 1.02M 2026-02-12 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap OtherAssetsCurrent Other Assets, Current USD 30,205 2013-08-31 2013 FY 10-K 2013-11-27 0001178913-13-003442
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 46,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD 15,869 2011-09-01 2012-05-31 2012 Q3 10-Q 2012-07-12 0001178913-12-001916
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -3,000 2014-09-01 2015-08-31 2015 FY 10-K 2015-11-25 0001213900-15-009096
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 301,000 2017-09-01 2018-08-31 2019 FY 10-K 2019-11-27 0001213900-19-024940
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 303,403 2002-04-12 2013-08-31 2013 FY 10-K 2013-11-27 0001178913-13-003442
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Net of Tax (Deprecated 2013-01-31) USD -50,687 2002-04-12 2013-02-28 2013 Q2 10-Q 2013-04-11 0001178913-13-001073
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax USD 80,000 2013-09-01 2014-08-31 2016 FY 10-K 2016-11-25 0001213900-16-018954
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI for Write-down of Securities, Net of Tax USD 130,845 2002-04-12 2013-08-31 2013 FY 10-K 2013-11-27 0001178913-13-003442
us-gaap OtherComprehensiveIncomeReclassificationAdjustmentForWriteDownOfSecuritiesIncludedInNetIncomeNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment for Write-down of Securities Included in Net Income, Net of Tax (Deprecated 2012-01-31) USD -117,347 2002-04-12 2012-11-30 2013 Q1 10-Q 2012-12-26 0001178913-12-003519
us-gaap OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax USD 301,000 2017-09-01 2018-08-31 2019 FY 10-K 2019-11-27 0001213900-19-024940
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 763,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap OtherExpenses Other Expenses USD 1.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 984,550 2002-04-12 2013-08-31 2013 FY 10-K 2013-11-27 0001178913-13-003442
us-gaap OtherGeneralExpense Other General Expense USD 1.04M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap OtherIncome Other Income USD 9.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap OtherInvestments Other Investments USD 1,000 2024-03-31 2024 Q1 10-Q 2024-05-09 0001213900-24-041364
us-gaap OtherInvestmentsAndSecuritiesAtCost Other Investments and Securities, at Cost USD 595,000 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap OtherLaborRelatedExpenses Other Labor-related Expenses USD 983,399 2002-04-12 2013-08-31 2013 FY 10-K 2013-11-27 0001178913-13-003442
us-gaap OtherLiabilities Other Liabilities USD 63,000 2024-03-31 2024 Q1 10-Q 2024-05-09 0001213900-24-041364
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 1.71M 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap OtherLiabilitiesFairValueDisclosure Other Liabilities, Fair Value Disclosure USD 637,182 2012-08-31 2013 FY 10-K 2013-11-27 0001178913-13-003442
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 60,000 2024-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap OtherLoansPayable Other Loans Payable ILS 800,000 2026-06-30 2026 Q2 10-Q 2026-08-10 0001213900-26-087361
us-gaap OtherLongTermDebt Other Long-term Debt USD 25.00M 2021-08-31 2021 FY 10-K 2021-11-24 0001213900-21-062009
us-gaap OtherLongTermDebtCurrent Other Long-term Debt, Current USD 25.01M 2021-08-31 2021 FY 10-K 2021-11-24 0001213900-21-062009
us-gaap OtherLongTermInvestments Other Long-term Investments USD 1.92M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap OtherMinorityInterests Other Noncontrolling Interests USD 1.50M 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap OtherNoninterestExpense Other Noninterest Expense USD 853,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 8.38M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 5.24M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 180,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap OtherPaymentsToAcquireBusinesses Other Payments to Acquire Businesses USD 25.00M 2020-09-01 2021-08-31 2021 FY 10-K 2021-11-24 0001213900-21-062009
us-gaap OtherRealEstate Other Real Estate USD 22.65M 2025-03-24 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap OtherReceivables Other Receivables USD 877,000 2025-01-02 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 2,000 2015-02-28 2015 Q2 10-Q 2015-04-03 0001178913-15-001193
us-gaap OtherSellingAndMarketingExpense Other Selling and Marketing Expense USD 663,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap OtherSellingGeneralAndAdministrativeExpense Other Selling, General and Administrative Expense USD 1.26M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0001213900-23-038593
us-gaap OtherShortTermBorrowings Other Short-term Borrowings USD 99.55M 2023-08-08 2024 Q1 10-Q 2024-05-09 0001213900-24-041364
us-gaap OtherShortTermInvestments Other Short-term Investments USD 195,000 2024-03-31 2024 Q1 10-Q 2024-05-09 0001213900-24-041364
us-gaap OtherSignificantNoncashTransactionValueOfConsiderationGiven1 Other Significant Noncash Transaction, Value of Consideration Given USD 628,000 2012-09-01 2013-08-31 2014 FY 10-K 2014-11-14 0001178913-14-003555
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net USD 434,876 2002-04-12 2014-02-28 2014 Q2 10-Q 2014-04-10 0001178913-14-001274
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net, Available-for-sale Securities USD 184,000 2011-09-01 2012-08-31 2014 FY 10-K 2014-11-14 0001178913-14-003555
us-gaap PaymentsForFees Payments for Other Fees USD 1.50M 2025-07-22 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap PaymentsForLoans Payments for Loans USD 1.83M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001213900-25-109980
us-gaap PaymentsForProceedsFromDepositOnLoan Payments for (Proceeds from) Deposit on Loan USD -99.55M 2023-01-01 2023-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095397
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 1,000 2016-09-01 2017-02-28 2017 Q2 10-Q 2017-04-05 0001178913-17-001061
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 732,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap PaymentsForRepurchaseOfOtherEquity Payments for Repurchase of Other Equity USD 2.70M 2022-08-26 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap PaymentsForRepurchaseOfPrivatePlacement Payments for Repurchase of Private Placement USD 18.00M 2026-01-12 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap PaymentsOfDividends Payments of Dividends USD 10.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 815,500 2013-09-01 2014-05-31 2014 Q3 10-Q 2014-07-14 0001178913-14-002290
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 1.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap PaymentsToAcquireEquityMethodInvestments Payments to Acquire Equity Method Investments USD 7.00M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap PaymentsToAcquireHeldToMaturitySecurities Payments to Acquire Held-to-maturity Securities USD 10.36M 2020-09-01 2021-08-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 775,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 1.95M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076668
us-gaap PaymentsToAcquireLand Payments to Acquire Land ILS 5.80M 2025-01-01 2025-01-31 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap PaymentsToAcquireLoansHeldForInvestment Payments to Acquire Loans Held-for-investment USD 7.00M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044193
us-gaap PaymentsToAcquireLongtermInvestments Payments to Acquire Long-term Investments USD 5,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 25.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap PaymentsToAcquireNotesReceivable Payments to Acquire Notes Receivable USD 3.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap PaymentsToAcquireOtherInvestments Payments to Acquire Other Investments USD 2.13M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 11,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap PaymentsToAcquireRealEstateHeldForInvestment Payments to Acquire Real Estate Held-for-investment USD 1.92M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap PaymentsToAcquireRestrictedCertificatesOfDeposit Payments to Acquire Restricted Certificates of Deposit USD 868,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 10.95M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent Liability, Defined Benefit Plan, Noncurrent USD 20,000 2021-05-31 2021 Q3 10-Q 2021-07-14 0001213900-21-036889
us-gaap PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage pure 0.05 2022-08-26 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap PrepaidExpenseAndOtherAssets Prepaid Expense and Other Assets USD 1.42M 2023-03-31 2023 Q1 10-Q 2023-05-11 0001213900-23-038593
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.04M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 450,000 2026-03-31 2026 Q1 10-Q 2026-05-19 0001213900-26-059112
us-gaap PrepaidPensionCosts Prepaid Pension Costs (Deprecated 2017-01-31) USD 13,000 2017-05-31 2017 Q3 10-Q 2017-07-06 0001213900-17-007202
us-gaap PrincipalAmountOutstandingOfLoansHeldInPortfolio Principal Amount Outstanding of Loans Held-in-portfolio ILS 2.00M 2026-09-09 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap PrincipalTransactionsRevenue Principal Transactions Revenue, Net USD 35.00M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068992
us-gaap ProceedsFromBankDebt Proceeds from Bank Debt USD 99.55M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085310
us-gaap ProceedsFromConstructionLoansPayable Proceeds from Construction Loans Payable USD 99.55M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 275,000 2002-04-12 2014-02-28 2014 Q2 10-Q 2014-04-10 0001178913-14-001274
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 26.25M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085310
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 2.43M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 300,000 2024-01-01 2024-12-31 2025 Q3 10-Q 2025-11-13 0001213900-25-109980
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 118,000 2013-09-01 2014-02-28 2015 Q2 10-Q 2015-04-03 0001178913-15-001193
us-gaap ProceedsFromLicenseFeesReceived Proceeds from License Fees Received USD 3.00M 2016-01-28 2016-01-31 2017 Q3 10-Q 2017-07-06 0001213900-17-007202
us-gaap ProceedsFromMinorityShareholders Proceeds from Noncontrolling Interests USD 1.50M 2020-09-01 2021-08-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 120,000 2002-04-12 2014-02-28 2014 Q2 10-Q 2014-04-10 0001178913-14-001274
us-gaap ProceedsFromOtherDebt Proceeds from Other Debt USD 99.55M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 118,128 2002-04-12 2014-02-28 2014 Q2 10-Q 2014-04-10 0001178913-14-001274
us-gaap ProceedsFromRefundsFromSuppliersOfMaterial Proceeds from Refunds from Suppliers of Material USD 20.00M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076668
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 22.38M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001213900-25-109980
us-gaap ProceedsFromRepaymentsOfDebt Proceeds from (Repayments of) Debt USD 3.63M 2025-07-01 2025-07-31 2025 Q3 10-Q 2025-11-13 0001213900-25-109980
us-gaap ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities Proceeds from Sale and Maturity of Held-to-maturity Securities USD 2.78M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-19 0001213900-26-059112
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 26.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments Proceeds from Sale, Maturity and Collection of Short-term Investments USD 59.50M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065678
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 137,555 2013-09-01 2014-05-31 2014 Q3 10-Q 2014-07-14 0001178913-14-002290
us-gaap ProceedsFromSaleOfAvailableForSaleSecurities Proceeds from Sale of Available-for-sale Securities USD 137,000 2013-09-01 2014-08-31 2016 FY 10-K 2016-11-25 0001213900-16-018954
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesEquity Proceeds from Sale of Available-for-sale Securities, Equity USD 80,000 2013-09-01 2014-02-28 2015 Q2 10-Q 2015-04-03 0001178913-15-001193
us-gaap ProceedsFromSaleOfEquityMethodInvestments Proceeds from Sale of Equity Method Investments USD 6.25M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap ProceedsFromSaleOfHeldToMaturitySecurities Proceeds from Sale of Held-to-maturity Securities USD 3.38M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap ProceedsFromSaleOfLongtermInvestments Proceeds from Sale of Long-term Investments USD 5,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap ProceedsFromSaleOfOtherInvestments Proceeds from Sale of Other Investments USD 7.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap ProceedsFromSaleOfOtherProductiveAssets Proceeds from Sale of Other Productive Assets USD 24,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 24,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 10.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 184,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 6.12M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap ProfessionalFees Professional Fees USD 40 2008-07-01 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 134.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 145,000 2015-08-31 2015 FY 10-K 2015-11-25 0001213900-15-009096
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 506,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 275,000 2002-04-12 2013-08-31 2013 FY 10-K 2013-11-27 0001178913-13-003442
us-gaap PurchaseObligation Purchase Obligation USD 6.00M 2020-08-21 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap RealEstateInvestments Real Estate Investments, Net USD 1.92M 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap ReceivableWithImputedInterestFaceAmount Receivable with Imputed Interest, Face Amount USD 2.56M 2023-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap RepaymentsOfBankDebt Repayments of Bank Debt USD 70.15M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0001213900-24-041364
us-gaap RepaymentsOfConstructionLoansPayable Repayments of Construction Loans Payable USD 25.00M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085310
us-gaap RepaymentsOfDebt Repayments of Debt USD 49.55M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 120,000 2002-04-12 2014-02-28 2014 Q2 10-Q 2014-04-10 0001178913-14-001274
us-gaap RepaymentsOfOtherDebt Repayments of Other Debt USD 64.20M 2024-01-01 2024-12-31 2025 Q3 10-Q 2025-11-13 0001213900-25-109980
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 500,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 1.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 16,000 2014-08-31 2014 FY 10-K 2014-11-14 0001178913-14-003555
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 16,000 2017-08-31 2018 FY 10-K 2018-11-28 0001213900-18-016666
us-gaap RestrictedStockAwardForfeitures Restricted Stock Award, Forfeitures USD 662,000 2021-09-01 2021-12-31 2021 Q2 10-QT 2022-03-30 0001213900-22-016230
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD 11.45M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 17,000 2014-09-01 2015-02-28 2015 Q2 10-Q 2015-04-03 0001178913-15-001193
us-gaap RevenueRecognitionMilestoneMethodRevenueRecognized Revenue Recognition, Milestone Method, Revenue Recognized USD 20.50M 2020-09-01 2021-05-31 2021 Q3 10-Q 2021-07-14 0001213900-21-036889
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 2.00M 2023-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap Revenues Revenues USD 2.00M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 58,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap RoyaltyRevenue Royalty Revenue (Deprecated 2018-01-31) USD 2.19M 2016-09-01 2017-08-31 2017 FY 10-K 2017-11-29 0001213900-17-012754
us-gaap SalariesAndWages Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold ILS 46.90M 2022-10-15 2022-11-01 2023 Q3 10-Q 2023-11-09 0001213900-23-085310
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 1.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap SaleOfStockConsiderationReceivedPerTransaction Sale of Stock, Consideration Received Per Transaction USD 49.50M 2015-12-25 2015-12-28 2018 Q1 10-Q 2018-01-11 0001213900-18-000390
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 11.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap SaleOfStockPercentageOfOwnershipAfterTransaction Sale of Stock, Percentage of Ownership after Transaction pure 0.099 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0001213900-24-041364
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 376,000 2023-01-01 2023-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068992
us-gaap ServicingAssetsAndServicingLiabilitiesAtFairValueAssumptionsUsedToEstimateFairValueDiscountRate Servicing Assets and Servicing Liabilities at Fair Value, Assumptions Used to Estimate Fair Value, Discount Rate pure 0.32 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap SeveranceCosts Severance Costs (Deprecated 2013-01-31) USD 5,615 2011-09-01 2012-08-31 2012 FY 10-K 2012-12-12 0001178913-12-003413
us-gaap SeveranceCosts1 Severance Costs USD 26,000 2014-09-01 2015-08-31 2015 FY 10-K 2015-11-25 0001213900-15-009096
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 6.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardCompensationCost Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost (Deprecated 2012-01-31) USD 15,211 2011-07-01 2011-07-31 2012 FY 10-K 2012-12-12 0001178913-12-003413
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 Share-based Payment Arrangement, Expensed and Capitalized, Amount USD 93,000 2015-09-01 2016-08-31 2016 FY 10-K 2016-11-25 0001213900-16-018954
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 9.59M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 870 2018-09-01 2019-08-31 2020 FY 10-K 2020-11-24 0001213900-20-038924
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 2.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 921,302 2021-08-31 2021 FY 10-K 2021-11-24 0001213900-21-062009
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 8,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 550,000 2023-04-17 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 2.45 2023-05-01 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2021-08-01 2021-08-04 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term, Maximum (Deprecated 2012-01-31) pure 6 2011-09-01 2012-08-31 2012 FY 10-K 2012-12-12 0001178913-12-003413
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term, Minimum (Deprecated 2012-01-31) pure 5 2011-09-01 2012-08-31 2012 FY 10-K 2012-12-12 0001178913-12-003413
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.62 2021-08-01 2021-08-04 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.755 2012-09-01 2013-08-31 2014 FY 10-K 2014-11-14 0001178913-14-003555
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.644 2012-09-01 2013-08-31 2014 FY 10-K 2014-11-14 0001178913-14-003555
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.008 2021-08-01 2021-08-04 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.01 2012-09-01 2013-08-31 2014 FY 10-K 2014-11-14 0001178913-14-003555
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.009 2012-09-01 2013-08-31 2014 FY 10-K 2014-11-14 0001178913-14-003555
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 4,200 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations shares 130,705 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted shares 400,140 2019-09-01 2020-08-31 2021 FY 10-K 2021-11-24 0001213900-21-062009
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 20,000 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.26M 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 4.50M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 144,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 4.08 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 48,334 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 11,394 2017-02-01 2017-02-09 2017 Q3 10-Q 2017-07-06 0001213900-17-007202
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value USD/shares 213,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 34,000 2024-06-20 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 7.99 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 665,000 2022-09-18 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 86,500 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085310
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price USD/shares 6.86 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 4.13 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 500,000 2025-01-02 2026 Q1 10-Q 2026-05-19 0001213900-26-059112
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 959,803 2026-03-30 2026 Q1 10-Q 2026-05-19 0001213900-26-059112
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum pure 0.25 2021-08-21 2021-09-02 2021 Q2 10-QT 2022-03-30 0001213900-22-016230
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased USD/shares 2.34 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068992
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 13,000 2025-01-02 2025 Q3 10-Q 2025-11-13 0001213900-25-109980
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 5.03 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 6.02 2019-09-01 2020-08-31 2020 FY 10-K 2020-11-24 0001213900-20-038924
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 10.59 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 2.21 2024-06-20 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 0.3 2012-08-31 2012 FY 10-K 2012-12-12 0001178913-12-003413
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm1 Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) pure 2.74 2012-08-31 2012 FY 10-K 2012-12-12 0001178913-12-003413
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit USD/shares 7.25 2017-09-01 2018-08-31 2018 FY 10-K 2018-11-28 0001213900-18-016666
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 132,000 2023-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 50,000 2026-07-31 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 8.47 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1 Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) pure 3.18 2012-08-31 2012 FY 10-K 2012-12-12 0001178913-12-003413
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit USD/shares 7.813 2017-09-01 2018-08-31 2018 FY 10-K 2018-11-28 0001213900-18-016666
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost Share-based Goods and Nonemployee Services Transaction, Capitalized Cost USD 857,000 2017-09-01 2018-05-31 2018 Q3 10-Q 2018-07-12 0001213900-18-009132
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued Share-based Goods and Nonemployee Services Transaction, Quantity of Securities Issued shares 2,500 2017-09-01 2018-08-31 2018 FY 10-K 2018-11-28 0001213900-18-016666
us-gaap SharePrice Share Price USD/shares 8.47 2022-07-28 2022 Q3 10-Q 2022-11-10 0001213900-22-071222
us-gaap SharesHeldInEmployeeStockOptionPlanSuspenseShares Shares held in Employee Stock Option Plan, Suspense Shares shares 563,646 2019-08-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap SharesIssued Shares, Issued shares 18,000 2022-01-03 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 2.85 2026-06-30 2026 Q2 10-Q 2026-08-10 0001213900-26-087361
us-gaap ShortTermBorrowings Short-term Debt USD 99.55M 2023-08-08 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap ShorttermDebtFairValue Short-term Debt, Fair Value USD 26.92M 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap ShortTermDebtInterestRateIncrease Short-term Debt, Interest Rate Increase pure 0.03 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065678
us-gaap ShortTermDebtPercentageBearingFixedInterestRate Short-term Debt, Percentage Bearing Fixed Interest Rate pure 0.15 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065678
us-gaap ShortTermInvestments Short-term Investments USD 57.45M 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095397
us-gaap SponsorFees Sponsor Fees ILS 88.02M 2022-10-15 2022-11-01 2023 Q3 10-Q 2023-11-09 0001213900-23-085310
us-gaap StockGrantedDuringPeriodValueSharebasedCompensationForfeited Shares Granted, Value, Share-based Payment Arrangement, Forfeited USD 100,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065678
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 199.74M 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 339.09M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap StockholdersEquityNoteStockSplitConversionRatio Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31) pure 12 2012-12-01 2013-02-28 2013 Q2 10-Q 2013-04-11 0001178913-13-001073
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio Rate 0.083 2013-01-01 2013-01-22 2014 FY 10-K 2014-11-14 0001178913-14-003555
us-gaap StockholdersEquityOtherShares Stockholders' Equity, Other Shares shares 1.97M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001213900-23-085310
us-gaap StockIssued1 Stock Issued USD 77,779 2002-04-12 2014-02-28 2014 Q2 10-Q 2014-04-10 0001178913-14-001274
us-gaap StockIssuedDuringPeriodSharesIssuedForCash Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) shares 1.58M 2013-09-01 2014-05-31 2014 Q3 10-Q 2014-07-14 0001178913-14-002290
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 17 2018-03-01 2018-05-31 2019 Q3 10-Q 2019-07-10 0001213900-19-012456
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 1.16M 2015-12-25 2015-12-28 2018 FY 10-K 2018-11-28 0001213900-18-016666
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 398,965 2013-09-01 2014-05-31 2014 Q3 10-Q 2014-07-14 0001178913-14-002290
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited Stock Issued During Period, Shares, Restricted Stock Award, Forfeited shares 110,917 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 22 2020-09-01 2021-08-31 2021 FY 10-K 2021-11-24 0001213900-21-062009
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures shares 680,000 2021-02-01 2021-02-03 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap StockIssuedDuringPeriodSharesReverseStockSplits Stock Issued During Period, Shares, Reverse Stock Splits shares 1.82M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 4,500 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-06 0001213900-24-020485
us-gaap StockIssuedDuringPeriodSharesStockSplits Stock Issued During Period, Shares, Stock Splits shares 1.00M 2019-08-01 2019-08-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 2.54M 2020-09-01 2021-08-31 2022 FY 10-K 2023-03-06 0001213900-23-017837
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 275,000 2007-09-01 2008-08-31 2014 Q2 10-Q 2014-04-10 0001178913-14-001274
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 14.89M 2013-09-01 2014-08-31 2014 FY 10-K 2014-11-14 0001178913-14-003555
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 9,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 2.43M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 22.38M 2021-09-01 2021-11-30 2022 Q1 10-Q 2022-01-11 0001213900-22-001563
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 434,876 2002-04-12 2007-08-31 2014 Q2 10-Q 2014-04-10 0001178913-14-001274
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 6.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 1.89M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065678
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 184,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense Stock Issued, Value, Stock Options Exercised, Net of Tax Benefit (Expense) USD 10,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap StockOptionExercisePriceDecrease Stock Option, Exercise Price, Decrease USD/shares 5.4 2026-02-12 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap StockOptionExercisePriceIncrease Stock Option, Exercise Price, Increase USD/shares 3.69 2026-07-01 2026-07-31 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 732,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 12.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 20.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap TaxCreditCarryforwardValuationAllowance Tax Credit Carryforward, Valuation Allowance USD 36.12M 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap TaxesPayableCurrentAndNoncurrent Taxes Payable USD 11,000 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095397
us-gaap TradingSecuritiesDebtAmortizedCost Debt Securities, Trading, Amortized Cost USD 1.09M 2020-11-30 2021 Q1 10-Q 2021-01-14 0001213900-21-002235
us-gaap TradingSecuritiesEquityCost Trading Securities, Equity, Cost USD 595,000 2021-02-28 2021 Q2 10-Q 2021-04-13 0001213900-21-021393
us-gaap TravelAndEntertainmentExpense Travel and Entertainment Expense USD 673,126 2002-04-12 2013-08-31 2013 FY 10-K 2013-11-27 0001178913-13-003442
us-gaap TreasuryStockAcquiredAverageCostPerShare Treasury Stock Acquired, Average Cost Per Share USD/shares 2.36 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003450
us-gaap TreasuryStockRetiredCostMethodAmount Treasury Stock, Retired, Cost Method, Amount USD 1.29M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095397
us-gaap TreasuryStockShares Treasury Stock, Shares shares 33,333 2021-09-02 2021 Q2 10-QT 2022-03-30 0001213900-22-016230
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 87,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 11,000 2023-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD -11,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap UnrecordedUnconditionalPurchaseObligationImputedInterest Unrecorded Unconditional Purchase Obligation, Imputed Interest USD 35,000 2023-06-30 2023 Q2 10-Q 2023-08-10 0001213900-23-065678
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -7.74M 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap WarrantExercisePriceDecrease Warrant, Exercise Price, Decrease USD/shares 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap WarrantExercisePriceIncrease Warrant, Exercise Price, Increase USD/shares 0.35 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001213900-26-034835
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 637,182 2012-08-31 2013 FY 10-K 2013-11-27 0001178913-13-003442
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 42.24M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-10 0001213900-26-087361
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 42.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 37.11M 2021-09-01 2021-12-31 2021 Q2 10-QT 2022-03-30 0001213900-22-016230
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 4.85M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0001213900-24-041364
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 41.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-119064

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →